Ritaskrá Háskóla Íslands - 01.05.2007, Qupperneq 78

78
NMR spectroscopy and methylation analysis. Carbohydrate
Research, 2006, 341 (14), 2449-2455. Omarsdottir S,
Petersen BO, Paulsen BS, Togola A, Duus JO, Olafsdottir
ES.
Structural characterisation of a highly branched galactomannan
from the lichen Peltigera canina by methylation analysis
and NMR-spectroscopy. Carbohydrate Polymers, 2006, 63
(1), 54-60. Omarsdottir S, Petersen BO, Barsett H, Paulsen
BS, Duus JO, Olafsdottir ES.
Fyrirlestur
Antiviral compounds from Icelandic lichens. 54th Annual
Congress on Medicinal Plant Research, Helsinki, 29. ágúst-
2. september 2006. 31. ágúst 2006. Omarsdottir S, Óladóttir
AK, Árnadóttir T, Ingólfsdóttir K. Flytjandi: Sesselja
Ómarsdóttir.
Veggspjöld
Antibacterial compounds from Vaccinium myrtillus (bilberry).
54th Annual Congress on Medicinal Plant Research,
Helsinki, 29. ágúst-2. september 2006. Kynnt 30. ágúst.
2006. Bessadóttir M, Jónsdóttir Í, Omarsdottir S,
Erlendsdóttir H, Ingólfsdóttir K.
Immunomodulating effects of lichen-derived polysaccharides
on monocyte-derived dendrtic cells. 54th Annual Congress
on Medicinal Plant Research, Helsinki, 29. ágúst-2.
september 2006. Kynnt 31. ágúst 2006. Omarsdottir S,
Olafsdottir ES, Freysdottir J.
Structural characterization of two galactofuranomannan
isolated from the lichen Thamnolia vermicularis var.
subuliformis. 54th Annual Congress on Medicinal Plant
Research, Helsinki, 29. ágúst-2. september 2006. Kynnt 31.
ágúst 2006. Omarsdottir S, Petersen BO, Paulsen BS,
Togola A, Duus JÖ, Olafsdottir ES.
Fræðsluefni
Fyrirlestur um gildi fæðubótarefna (kostir/gallar/aukaverkanir)
haldinn fyrir Umhverfisstofnun, 18. október 2006.
Sveinbjörn Gizurarson prófessor
Grein í ritrýndu fræðiriti
Gizurarson S, Bechgaard E, Hjortkjær RK. Two intranasal
administration techniques give two different pharmacokin-
etic results. Scand. J. Lab. Animal Sci. 33 (1) 35-38, 2006.
Fyrirlestrar
Gizurarson S. (Invited lecturerer). Immunology of the nasal
cavity. Annual International Event: Nasal Drug Delivery –
Exploring this Rapidly Developing Area. London, UK, March
2006.
Gizurarson S. (Invited lecturerer). Toxicology testing of nasal
products for local and systemic treatment. Annual
International Event: Nasal Drug Delivery – Exploring this
Rapidly Developing Area. London, UK, March 2006.
Ritstjórn
Scandinavian Journal of Laboratory Animal Sciences.
Útdrættir
Freysdóttir J, Harðardóttir I, Gizurarson S, Víkingsson A.
Mucosal tolerance to KLH reduces BSA-induced arthritis in
rats – an indication of bystander suppression. Scand. J.
Rheumatol. 121 (Suppl) p. 22, 2006.
Freysdottir J, Bogason ET, Gizurarson S, Vikingsson A.
Influence of passive cigarette smoke on joint swelling and
on mucosal tolerance induction in BSA-induced arthritis.
Scand. J. Rheumatol. 121 (Suppl) p 44-45, 2006.
Þorsteinn Loftsson prófessor
Greinar í ritrýndum fræðiritum
K. M. Saari, L. H. Nelimarkka, V. Ahola, T. Loftsson and E.
Stefánsson. „Comparison of 0.7% dexamethasone-
cyclodextrin with 0.1% dexamethasone sodium phosphate
for postoperative inflammation“. Graefe’s Archive for
Clinical and Experimental Ophthalmology, 244, 620-626
(2006).
O. Dale, T. Nilsen, T. Loftsson, H. Hjorth Tønnesen, P. Klepstad,
S. Kaasa, T. Holand and Per G. Djupesland. „Unexpected
discrepancy between bioavailability and pharmacodynamic
effect in the CNS when comparing two nasal sprays“. J.
Pharm. Pharmacol., 58, 1311-1318 (2006).
M. Másson, T. Benediktsson, T. Thorsteinsson and T. Loftsson.
„Investigation of soft long chain quaternary ammonium
compounds as co-factors to enhance in-vitro gene
delivery“. Pharmazie, 61, 564-566 (2006).
T. Loftsson, F. Konráðsdóttir and M. Másson. „Influence of
aqueous diffusion layer on passive drug diffusion from
aqueous cyclodextrin solutions through biological
membranes“. Pharmazie, 61, 83-89 (2006).
T. Loftsson and D. Hreinsdóttir. „Determination of aqueous
solubility by heating and equilibration: a technical note“.
AAPS PharmSciTech, 7(1) (2006)
(http://www.aapspharmscitech.org).
H.H. Sigurdsson, T. Loftsson and C.-M. Lehr. „Assessment of
mucoadhesion by a resonant mirror biosensor“. Int. J.
Pharm., 325, 75-81 (2006).
S.H. Hardarson, H.H. Sigurdsson, G.E. Níelsdóttur, J.
Valgeirsson, T. Loftsson and E. Stefánsson. „Ocular
powder: dry topical formulations of timolol are well
tolerated in rabbits“. Journal of Ocular Pharmacology and
Therapeutics 22, 340-346 (2006).
T. Loftsson, F. Konrádsdóttir and M. Másson. „Development and
evaluation of an artificial membrane for determination of
drug availability“. Int. J. Pharm. 326, 60-68 (2006).
Annað efni í ritrýndu fræðiriti
E. Stefánsson and T. Loftsson. „The Stokes-Einstein equation
and the physiological effects of vitreous surgery“. Acta
Ophthalmol. Scand., 84, 718-719 (2006). [Editorial material].
Bókarkafli og kafli í ráðstefnuriti
Þorsteinn Loftsson, „The pharmaceutical education in Iceland“,
Quality Assurance in Pharmacy Education, Peep Veski, Ed.,
European Association of Faculties of Pharmacy.
Ráðstefnurit vegna EAFP Annual Conference, 8-10 June
2006, Tallinn – Tartu, Estonia. Bls. 71-74.
Þorsteinn Loftsson, „Aquavitae. Áhrif vatns á lyfjaþróun“ í
Vísindin heilla – Sigmundur Guðbjarnason 75 ára
(Guðmundur G. Haraldsson ritstjóri), Háskólaútgáfan,
Reykjavík 2006.
Fyrirlestrar
T. Loftsson. „Cyclodextrin aggregates, nanoparticles,
microparticles“. University of Kuopio (Finnland), Faculty of
Pharmacy, 12. september 2006.
T. Loftsson. „The Cyclodextrin Technology: aggregate formation
and drug delivery through biological membranes“.
Universidad de Santiago de Compostela, Facultad de
Farmacia, 9. nóvember 2006.
T. Loftsson. „Cyclodextrin nanotechnology and ophthalmic drug
delivery“. Plenary Lecture, XIII International Cyclodextrin
Symposium, Tórínó (Ítalíu), 14.-17. maí 2006.
Veggspjöld
T. Loftsson, E. Stefánsson, H.H. Sigurdsson and F.
Konradsdottir. „Topical drug delivery of dexamethasone to